| Mrs Shelley Pfitzner, MDC, CCC-SLP | |
|
2040 Fitzhugh St, Batesville, AR 72501-7409 | |
| (870) 793-3334 | |
| (870) 793-3474 |
| Full Name | Mrs Shelley Pfitzner |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 2040 Fitzhugh St, Batesville, Arkansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093842437 | NPI | - | NPPES |
| 5X752 | Other | AR | BLUE CROSS BLUE SHIELD NU |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 1976 (Arkansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Shelley Pfitzner, MDC, CCC-SLP 1520 Holcombe Cemetary Rd, Newark, AR 72562-9463 Ph: (870) 793-3334 | Mrs Shelley Pfitzner, MDC, CCC-SLP 2040 Fitzhugh St, Batesville, AR 72501-7409 Ph: (870) 793-3334 |
News Archive
Elderlink, Inc., a free senior care referral service serving California since 1994, is offering senior citizens and their families the ability to find the care they need via personalized referral lists based upon their individual needs.
Harvard University and Dana-Farber Cancer Institute announced today that they have concluded a major licensing agreement with Acetylon under which Harvard and Dana-Farber granted an exclusive therapeutic license to a robust platform technology and chemical methodology that enables high-throughput screening and lead optimization for HDAC inhibitor compounds.
Providing emergency contraception to women in advance of need does not reduce pregnancy rates, despite increased use and faster use after unprotected sexual intercourse. These are the findings according to a new review published in The Cochrane Library.
MicroStockProfit.com announces an investment report featuring BioElectronics Corp. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
New research published online in The FASEB Journal suggests that a novel therapeutic target called LPCAT2 may prove effective against pain that is not receptive to the current treatments.
› Verified 9 days ago
Mrs. Jill Overturf, MCD, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2040 Fitzhugh St, Batesville, AR 72501 Phone: 870-793-3334 Fax: 870-793-3474 | |
Chelsea Sanderson, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 415 Allen St, Batesville, AR 72501 Phone: 870-793-2877 | |
Christine Wilkerson, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1710 Harrison St, Batesville, AR 72501 Phone: 870-262-1271 Fax: 870-262-6013 | |
Taylor Mynatt, SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1000 White Drive, Batesville, AR 72501 Phone: 870-793-2877 | |
Mrs. Jennifer K. Harmon, MCD, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 70 Scott Dr, Batesville, AR 72501 Phone: 870-251-2341 Fax: 870-251-3316 | |
Sarah Poole, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 2955 Juniper Dr, Batesville, AR 72501 Phone: 870-613-9006 |